Clinical Trial Update: Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating the optimal titration regimen of SBR759 to lower serum phosphate in Asian patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SBR759

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED